NOTR — BioScience Health Innovations Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for BioScience Health Innovations, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 August 31st | 2021 August 31st | 2022 November 30th | 2022 August 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-Q | 10-K | 10-K |
Standards: | USG | USG | — | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.021 | 0.002 | 0.028 | 0.016 | 0.663 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | — | — | 0.122 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.021 | 0.006 | 0.028 | 0.016 | 0.848 |
Net Intangible Assets | |||||
Total Assets | 0.021 | 0.006 | 0.028 | 0.016 | 0.874 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.008 | 0.019 | 0.003 | 0.002 | 0.039 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.008 | 0.019 | 0.003 | 0.002 | 0.039 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0.013 | -0.013 | 0.025 | 0.014 | 0.835 |
Total Liabilities & Shareholders' Equity | 0.021 | 0.006 | 0.028 | 0.016 | 0.874 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |